- Home
- SSSS vs IOBT Comparison
SSSS vs IOBT Comparison
Compare SSSS & IOBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SSSS
- IOBT
- Stock Information
- Founded
- SSSS 2010
- IOBT 2014
- Country
- SSSS United States
- IOBT Denmark
- Employees
- SSSS N/A
- IOBT N/A
- Industry
- SSSS Finance: Consumer Services
- IOBT Biotechnology: Pharmaceutical Preparations
- Sector
- SSSS Finance
- IOBT Health Care
- Exchange
- SSSS Nasdaq
- IOBT Nasdaq
- Market Cap
- SSSS 138.2M
- IOBT 114.6M
- IPO Year
- SSSS N/A
- IOBT 2021
- Fundamental
- Price
- SSSS $9.10
- IOBT $1.84
- Analyst Decision
- SSSS Strong Buy
- IOBT Strong Buy
- Analyst Count
- SSSS 4
- IOBT 2
- Target Price
- SSSS $9.50
- IOBT $8.00
- AVG Volume (30 Days)
- SSSS 263.3K
- IOBT 1.9M
- Earning Date
- SSSS 11-06-2025
- IOBT 11-11-2025
- Dividend Yield
- SSSS 10.96%
- IOBT N/A
- EPS Growth
- SSSS N/A
- IOBT N/A
- EPS
- SSSS 2.22
- IOBT N/A
- Revenue
- SSSS $2,784,381.00
- IOBT N/A
- Revenue This Year
- SSSS $6.95
- IOBT N/A
- Revenue Next Year
- SSSS N/A
- IOBT N/A
- P/E Ratio
- SSSS $4.11
- IOBT N/A
- Revenue Growth
- SSSS N/A
- IOBT N/A
- 52 Week Low
- SSSS $3.77
- IOBT $0.66
- 52 Week High
- SSSS $9.50
- IOBT $2.79
- Technical
- Relative Strength Index (RSI)
- SSSS 64.23
- IOBT 51.25
- Support Level
- SSSS $8.63
- IOBT $1.71
- Resistance Level
- SSSS $8.75
- IOBT $2.08
- Average True Range (ATR)
- SSSS 0.17
- IOBT 0.15
- MACD
- SSSS 0.03
- IOBT 0.02
- Stochastic Oscillator
- SSSS 55.56
- IOBT 56.36
About SSSS SuRo Capital Corp.
SuRo Capital Corp is a non-diversified closed-end management investment company. The company's investment objective is to maximize its portfolio's total return, principally by seeking capital gains on its equity and equity-related investments.
About IOBT IO Biotech Inc.
IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.